The Impax Patient Assistance Program provides brand name medications at no or low cost and is intended for patients that are uninsured or underinsured. Eligibility for patients with Medicare Part D will be determined on a case by case basis. Income requirements for this program have not been disclosed. Patients must be a US resident.
How do I contact Amneal or Impax?
Amneal, Impax and/or Gemini Laboratories Products: Report adverse events, product quality complaints and for medical information inquiries in the United States. Call: (877) 835-5472, option 1 or email: [email protected]
Are patient assistance programs (Paps) for drug manufacturers worth it?
We are all familiar with the patient assistance programs (PAPs) primarily sponsored by drug manufacturers or a partner organization and generally consider them a good thing for assisting patients with high out-of-pocket costs for expensive specialty drugs, especially in this era of high-deductible insurance plans.
What are the benefits of PAPs in healthcare?
Many health care systems have gone so far as to develop organized programs to connect patients with PAPs as a means of enhancing access to medications and reducing their financial burden. This is also potentially beneficial for the institution because it reduces bad debt.
Accredited Business
Guarantees that a business meets BBB accreditation standards in the US and Canada.
TopTen Reviews
Highest customer reviews on one of the most highly-trusted product review platforms.
Summary
Thank you for checking into Impax Laboratories, Inc patient assistance program. As of January 24th, 2012 we do not have any specific information related to Impax Laboratories, Inc's program. Please check back regularly as we are updating our database of information daily.
Eligibility
Most programs have income, age, and other eligibility requirements. At this current time we don´t have the eligibility information for Impax Laboratories, Inc's program.
Other Tips
If you have any questions please call the Impax Laboratories, Inc program directly.
How much is the maximum out of pocket cost for PAP?
For example, if the maximum allowable on the PAP is $15,000 per year, the patient’s out-of-pocket cost will be $1250 per month . That is, the co-pay becomes very flexible, based on the dollars available from the PAP, and the company takes every dollar available. Thus, if the patient does not sign up to participate in the maximizer program, their outof- pocket cost would be $15,000 per year under this example, because it is their “co-pay” for a nonessential health service. Under the maximizer arrangement, the patient’s out-of-pocket cost for treatment is $0, so there is no contribution to the deductible or maximum outof- pocket cost from their drug therapy.
Why is it important to connect patients with PAPs?
Many health care systems have gone so far as to develop organized programs to connect patients with PAPs as a means of enhancing access to medications and reducing their financial burden. This is also potentially beneficial for the institution because it reduces bad debt . At my organization, we have a new job category called medication access specialists, who, among other things, are responsible for connecting patients to PAPs and helping families and patients navigate the sometimes confusing process. Therefore, at the micro level, this is a good thing.
Why is not participating in PAP bad?
In fact, to not participate in a PAP can be interpreted as overpaying for a drug, somewhat like paying the list price for a new car. Of course, the exclusion of governmental insurance plans is unfortunate because these patients are often the ones in greatest need of financial assistance.
Can high cost drug therapy be used to eliminate deductible?
If patients on high-cost drug therapy know they are not assum ing that financial risk because of being able to use PAP money to eliminate their deductible, one could argue that the system is being gamed to some extent. In response, accumulator programs entered the arena.
Can you use PAP money to pay down deductible?
Understandably, employers and payers do not appreciate that PAP dollars are being used by patients to pay down their deductible and maximum out-of-pocket expense while the plan experiences escalating pharmacy benefit costs because of these expensive agents.
Who should not take EMVERM?
Do not take EMVERM if you are allergic to mebendazole or any of the ingredients in EMVERM. See the end of this Patient Information for a complete list of ingredients in EMVERM.
Before you take EMVERM, tell your healthcare provider about all of your medical conditions, including if you
are pregnant or plan to become pregnant. It is not known if EMVERM will harm your unborn baby.
What should I avoid while taking EMVERM?
Do not take EMVERM with metronidazole (a medicine used to treat bacterial and protozoan infections) as serious skin reactions called Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) can happen.
What are the possible side effects of EMVERM?
Low white blood cell count (neutropenia). Neutropenia can cause you to get other infections. Your healthcare provider will check your blood count regularly during your treatment with EMVERM. Tell your healthcare provider right away if you have a fever or any signs of an infection while taking EMVERM.
General information about the safe and effective use of EMVERM
Medicines are sometimes prescribed for purposes other than those listed in the Patient Information. Do not use EMVERM for a condition for which it was not prescribed. Do not give EMVERM to other people, even if they have the same symptoms that you have. It may harm them.
What are the ingredients in EMVERM?
Active ingredient: mebendazole. Inactive ingredients: microcrystalline cellulose, corn starch, anhydrous lactose NF, sodium starch glycolate, magnesium stearate, stearic acid, sodium lauryl sulfate, sodium saccharin, and FD&C Yellow #6.
What is EMVERM?
EMVERM is a prescription medicine used to treat adults and children 2 years of age and older with intestinal worm infections caused by pinworm, whipworm, roundworm, or hookworm.
